Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

208 Press Releases
DateTitleCompany
02 Jul 14 REAL WORLD DATA TO BE PRESENTED FOR FYCOMPA® (PERAMPANEL) Eisai,
Published by
toniclc.com
02 Jul 14 PAREXEL INTERNATIONAL ANNOUNCES ACQUISITION OF ATLAS MEDICAL SERVICES, A PROVIDER OF CLINICAL RESEARCH SERVICES IN TURKEY Parexel,
Published by
PharmiWeb.com
30 Jun 14 Emerging Data From The FIRE-3 Study, Shows Potentially Significant Improvements in tumour response and shrinkage in the subset of patients with RAS... Merck Serono,
Published by
Reynolds-MacKenzie
27 Jun 14 Novella Clinical Names Dr. Lynne Bui Senior Medical Director of Oncology Division Novella Clinical
25 Jun 14 Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research Orgenesis
25 Jun 14 Simbec Research Limited (“Simbec”) and ORION Clinical Services Limited (“ORION”) Simbec Research
25 Jun 14 PolyPid Wins First Prize at Biomed Startup Competition PolyPid,
Published by
Kanaan Public Relations
25 Jun 14 ONYX TO INVEST IN CONTINUOUS FLOW TECHNOLOGY Onyx Scientific
23 Jun 14 The Global Care Initiative consortium looks to the US for life sciences research partners Global Care Initiative,
Published by
Andrew Lloyd and Associates
23 Jun 14 Shire Launches Excellence in ADHD Patient Group Awards Shire plc
23 Jun 14 ABLYNX WINS TRANSACTION OF THE YEAR AT THE 2014 EUROPEAN MEDISCIENCE AWARDS Ablynx
19 Jun 14 New Cetraben® lotion – a convenient leave-on emollient launched by Thornton & Ross Thornton & Ross,
Published by
PharmiWeb.com
18 Jun 14 UCR (Uppsala Clinical Research Center) selected Ethical eAdjudication® to Support the Clinical Endpoints Adjudication Process Ethical GmbH
18 Jun 14 Magnet technology means new possibilities for cochlear implant users MED-EL Medical Electronics Ltd.
17 Jun 14 Coming to Europe- Best Pharma Market Research Conference: Oct 21-22, 2014, Germany Pharma Market Research Conference
17 Jun 14 Merck Millipore Launches Simplicon™ RNA Reprogramming Technology for Efficient Generation of Virus-Free iPSCs Merck Millipore,
Published by
PharmiWeb.com
17 Jun 14 New one-year data of IDegLira shows glucose-lowering effect was maintained for people with type 2 diabetes Novo Nordisk
17 Jun 14 New phase 3 study shows efficacy and safety of Victoza® for the treatment of type 2 diabetes in adults with moderate renal impairment Novo Nordisk
17 Jun 14 Penn Pharma receives multiple awards at the BVCA Management Team Awards 2014 Penn Pharma,
Published by
Remarkable PR
17 Jun 14 Tresiba® (insulin degludec) achieves significantly lower rate of nocturnal hypoglycaemia compared to insulin glargine in type 2 diabetes Novo Nordisk,
Published by
Pegasus
12 Jun 14 AstraZeneca in-licenses Synairgen's SNG001 as a novel immuno-modulatory therapy for viral-induced exacerbation in asthma AstraZeneca
11 Jun 14 Experts call for greater clarity on the prescribing and dispensing of vitamin D Internis Pharmaceuticals,
Published by
Packer Forbes Communications
11 Jun 14 PREMIER Biosoft announces the release of SimGlycan® Enterprise Edition 5.0 to support automated mass spectrometry glycan quantitation analysis using Thermo Scientific™ aminoxyTMT™ Reagents PREMIER Biosoft
10 Jun 14 Pharma industry encouraged to adopt mobile ePRO for clinical trials efficiency at DIA 2014 Exco InTouch,
Published by
PharmiWeb.com
10 Jun 14 Brightwork Group in drive to help solve skills shortage in Scotland's care sector Brightwork Group,
Published by
Brightwork
10 Jun 14 Cherwell Opens Expanded Redipor® Prepared Media Facility Cherwell Laboratories
10 Jun 14 Gene Expression Profiling Drives Personalized Medicine Worldwide, Finds Frost & Sullivan Frost & Sullivan
10 Jun 14 The US Food and Drug Administration (FDA) approves Eloctate(TM) Swedish Orphan Biovitrum,
Published by
Sobi
03 Jun 14 Cambridge Research Biochemicals and Key Organics announce an exclusive global supply & marketing agreement for peptides Cambridge Research Biochemicals,
Published by
Sciad Communications @ London Bioscience Innovatio
30 May 14 Novozymes Biopharma enters agreement with a leading vaccine company to conduct research on a novel subunit vaccine complex based on albumin fusion technology Novozymes Biopharma
Advertising